Sign in

CIK 0001593899

  • Non-accelerated filer
  • Smaller reporting company

Atea Pharmaceuticals, Inc.

Sign in to watch
Ticker
AVIR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
460574869
Phone
+1 857-284-8891
Business address
225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$319,804
in 3 filings

Net −$319,804. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Polsky Bruce −$203K Director sold 25% of stake
  2. Lucidi Bruno −$116K Director sold 14% of stake
Date Insider Transaction Shares Price Value Owned after
2026-01-31 Hammond Janet MJ Chief Development Officer Exercise or conversion +58,050 141,801
2026-01-31 Hammond Janet MJ Chief Development Officer Shares withheld for taxes −14,136 $4.24 $60K 127,665
2026-01-31 Hammond Janet MJ Chief Development Officer Exercise or conversion · Restricted Stock Units −46,800 0
2026-01-31 Hammond Janet MJ Chief Development Officer Exercise or conversion · Restricted Stock Units −11,250 0
2026-01-31 Hammond Janet MJ Chief Development Officer Grant or award · Stock Option (Right to Buy) +177,000 177,000
2025-01-31 Hammond Janet MJ Chief Development Officer Exercise or conversion +46,800 84,272
2025-01-31 Hammond Janet MJ Chief Development Officer Grant or award +11,250 95,522
2025-01-31 Hammond Janet MJ Chief Development Officer Shares withheld for taxes −14,134 $3.06 $43K 81,388
2025-01-31 Hammond Janet MJ Chief Development Officer Exercise or conversion · Restricted Stock Units −46,800 46,800
2025-01-31 Hammond Janet MJ Chief Development Officer Grant or award · Restricted Stock Units +11,250 11,250
2025-01-31 Hammond Janet MJ Chief Development Officer Grant or award · Stock Option (Right to Buy) +200,000 200,000
2024-02-01 Hammond Janet MJ Chief Development Officer Sale −14,029 $3.84 $54K 35,362
2024-01-31 Hammond Janet MJ Chief Development Officer Exercise or conversion +46,800 49,391
2024-01-31 Hammond Janet MJ Chief Development Officer Exercise or conversion · Restricted Stock Units −46,800 93,600
2024-01-31 Hammond Janet MJ Chief Development Officer Grant or award · Stock Option (Right to Buy) +225,200 225,200
2023-01-31 Hammond Janet MJ Chief Development Officer Grant or award · Restricted Stock Units +140,400 140,400
2023-01-31 Hammond Janet MJ Chief Development Officer Grant or award · Stock Option (Right to Buy) +196,600 196,600
2022-01-31 Hammond Janet MJ Chief Development Officer Grant or award · Stock Option (Right to Buy) +190,000 190,000
2021-01-29 Hammond Janet MJ Chief Development Officer Grant or award · Stock Option (Right to Buy) +160,050 160,050

Page 1 of 1 · 19 trades